Dealing with difficult service in the UPC: The cases of Philips IP Ventures v Belkin and Panasonic v Xiaomi as examples.
24 January 2024
Andrew is a Senior Counsel in the Patents team and offers expert counsel on contentious patent and regulatory matters. Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector.
Expertise
Services and Groups
Resolving patents & know-how disputes
Sectors
CV
Since 2024
Senior Counsel, Taylor Wessing
2020 - 2024
Senior Associate, Taylor Wessing
2015 - 2020
Associate, Taylor Wessing
2013 - 2015
Trainee Solicitor , CMS Cameron McKenna
2009 - 2013
Group Leader, Medicinal Chemistry at Eisai
2000 - 2009
Team Leader, GlaxoSmithKline
1998 - 1999
Postdoctoral Researcher, The University of Texas at Austin
2015
Admitted as a lawyer, England & Wales
2013
LPC distinction, BPP Law School
2011
GDL commendation, BPP Law School, London
1997
PhD in synthetic organic chemistry from Imperial College, London
1994
BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy
Career
Since 2024
Senior Counsel, Taylor Wessing
2020 - 2024
Senior Associate, Taylor Wessing
2015 - 2020
Associate, Taylor Wessing
2013 - 2015
Trainee Solicitor , CMS Cameron McKenna
2009 - 2013
Group Leader, Medicinal Chemistry at Eisai
2000 - 2009
Team Leader, GlaxoSmithKline
1998 - 1999
Postdoctoral Researcher, The University of Texas at Austin
Education
2015
Admitted as a lawyer, England & Wales
2013
LPC distinction, BPP Law School
2011
GDL commendation, BPP Law School, London
1997
PhD in synthetic organic chemistry from Imperial College, London
1994
BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy
Publications
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53
Additional languages
English
Andrew's news & insights
Life sciences & healthcare
Click here to find out more
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
30 March 2018
Briefing
by Andrew Payne
Life sciences & healthcare
Click here to find out more
Licence held to be exclusive despite option
28 February 2018
Briefing
by Andrew Payne
Related news & insights
Life sciences & healthcare
Click here to find out more
Higher Regional Court of Hamburg: On the risk classification of health apps
19 September 2024
Briefing
Life sciences & healthcare
Click here to find out more
Regional Court of Cologne: Ban on deliveries of medicinal products by bicycle courier on Sundays and public holidays in North Rhine-Westphalia
19 September 2024
Quick read
Life sciences & healthcare
Click here to find out more
Regional Court of Hamburg: Prohibition of a bonus programme for nursing staff because of violation of Section 7 para. 1 sentence 1 of the German Drug Advertising Act (HWG)
19 September 2024
Quick read
Consumer & retail
Click here to find out more
European Court of Justice on advertising for biocidal products: ‘Skin-friendly’ is misleading and violates EU law
19 September 2024
Quick read
Life sciences & healthcare
Click here to find out more
Regulatory Update: Microplastics and Medical Devices
18 September 2024
Quick read
Patents & innovation
Click here to find out more
Dealing with difficult service in the UPC: An Update
17 September 2024
Briefing
by multiple authors
USA
Click here to find out more
Taylor Wessing advises Lumivero on the acquisition of ATLAS.ti
17 September 2024
by multiple authors
Consumer & retail
Click here to find out more
Court of Appeal ruling raises bar for supply chain monitoring in the UK: World Uyghur Congress v National Crime Agency
17 September 2024
Quick read
by Giles Crown and Louise Popple
Life sciences & healthcare
Click here to find out more
Electronic instructions for use for medical devices
16 September 2024
Briefing
Life sciences & healthcare
Click here to find out more
Labelling requirements for medical devices under the new EU Product Safety Regulation
16 September 2024
Briefing
Related people
UK
Global